PTK2 and endometrial cancer: But Li and his team came to the conclusion that miR‐543 was decreased in endometrial cancer and suppressed endometrial cancer oncogenicity via targeting FAK and TWIST132 and XU et al. reported that miR‐543 might function as a tumor suppressor in patients with glioma.33